Benitec Biopharma Limited Additional Paid In Capital

Additional Paid In Capital of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Additional Paid In Capital growth rates and interactive chart.


Highlights and Quick Summary

  • Additional Paid In Capital for the quarter ending June 30, 2022 was $152 Million (a 0.11% increase compared to previous quarter)
  • Year-over-year quarterly Additional Paid In Capital increased by 0.39%
  • Annual Additional Paid In Capital for 2022 was $152 Million (a 0.57% increase from previous year)
  • Annual Additional Paid In Capital for 2021 was $152 Million (a 17.66% increase from previous year)
  • Annual Additional Paid In Capital for 2020 was $129 Million (a 1.18% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Additional Paid In Capital of Benitec Biopharma Limited

Most recent Additional Paid In Capitalof BNTC including historical data for past 10 years.

Interactive Chart of Additional Paid In Capital of Benitec Biopharma Limited

Benitec Biopharma Limited Additional Paid In Capital for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $152.45 $152.29 $152.45
2021 $152.09 $151.85 $151.58 $138.63 $151.58
2020 $138.4 $128.85 $128.83 $128.83
2019 $127.33
2016 $0.0
2015 $0.0
2014 $0.0
2013 $0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology